Continuing a Journey
of Science and Humanity
2023 Annual Report
Key achievements
A time of expansion and consolidation
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.
Expertise
We lead with knowledge
Kedrion is a worldwide leader in the production and distribution of plasma-derived therapies for rare diseases and conditions. What does this mean? What exactly is plasma? What are rare diseases and how do our products treat them?
Donations
The first step on the journey
Our ability to provide relief and protection to people suffering from serious and rare conditions depends on the generosity of plasma donors. Listen to some testimonials and discover the significant impact they have on people's lives.
Rare diseases
Rare is real
Rare is real. For a person suffering from a “rare” condition like Hemophilia, the experience is very real. However, rare and ultra-rare diseases could be seen as somehow “under the radar” of everyday reality for those not intimately familiar with them.
Innovation
Leading the way to helping people
Finding new and better ways to help more people is what innovation means to us. This is especially critical in the case of rare and ultra-rare diseases and conditions, where limited knowledge exists, making each new insight a valuable resource.
OneKedrion
Working together.
Becoming one.
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.
Neighborliness
Taking care of people and places
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.
Before you begin
How to navigate the report
Welcome to the Kedrion 2024 Annual Report. For this edition we have designed a new navigation experience. Here are some instruction to let you enjoy the experience.
Exploring
How to go around
To navigate the report you can use your mouse to push the screen in all directions. Alternatively, you can use the controls at the bottom of the screen to choose the direction you want to explore.
Finding your way
Getting back on track
Feeling lost? Click on the target icon to start over. If you prefer a more traditional navigation experience, you can click on the rectangular icon to switch to the gallery mode at any moment.
Table of contents
Get an overview
To see all the sections of the Annual Report at once, you can click on the “View chapters” button.
Download in PDF
Save for later
You can also dowload the report in PDF format by clicking on the “Download report” button.
Key achievements
A time of expansion and consolidation
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.
Expertise
We lead with knowledge
Kedrion is a worldwide leader in the production and distribution of plasma-derived therapies for rare diseases and conditions. What does this mean? What exactly is plasma? What are rare diseases and how do our products treat them?
Donations
The first step on the journey
Our ability to provide relief and protection to people suffering from serious and rare conditions depends on the generosity of plasma donors. Listen to some testimonials and discover the significant impact they have on people's lives.
Rare diseases
Rare is real
Rare is real. For a person suffering from a “rare” condition like Hemophilia, the experience is very real. However, rare and ultra-rare diseases could be seen as somehow “under the radar” of everyday reality for those not intimately familiar with them.
Innovation
Leading the way to helping people
Finding new and better ways to help more people is what innovation means to us. This is especially critical in the case of rare and ultra-rare diseases and conditions, where limited knowledge exists, making each new insight a valuable resource.
OneKedrion
Working together.
Becoming one.
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.
Neighborliness
Taking care of people and places
With new assets and increased capacities, the new Kedrion continues a Journey of Science and Humanity begun decades ago in Italy and in the UK. Join us on this remarkable journey and discover the milestones we achieved in 2023.